# Labiotech UG

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/labiotech

- Industry: Media
- Headquarters: Berlin, Germany
- Website: www.labiotech.eu
- Latest round: Seed (Sep 18, 2017)
- Investors on record: 6

## About

Labiotech UG is a digital media platform focused on the biotechnology sector, delivering industry news, insights, and analysis to life science professionals and researchers across Europe and beyond.Founded in 2014 and headquartered in Berlin, Germany, Labiotech UG specializes in providing a digital media platform for the biotechnology industry. In January 2022, Labiotech UG was acquired by Inova Software SA. The company has engaged in a total of 3 deals since inception, with the most recent deal occurring on January 20, 2022.Labiotech.eu operates as a leading digital media platform dedicated to the biotechnology sector, providing comprehensive coverage of industry news, trends, and insights. Its core offerings include in-depth articles, analyses, and reports focused on various facets of biotechnology, including drug development, gene therapy, and emerging technologies like CRISPR and AI in drug discovery. The platform serves a diverse audience comprising life science professionals, researchers, and industry enthusiasts across Europe and globally, facilitating access to valuable information that enhances collaboration and drives innovation. Key geographical markets include the United States, United Kingdom, and Germany, where biotech industries are robust and growing. By delivering timely and relevant content, Labiotech.eu addresses the critical need for updated information in a fast-paced sector, fostering a knowledgeable community among its users.Labiotech.eu generates revenue primarily through advertising partnerships and sponsored content, providing a platform for companies to engage with a targeted audience of biotech professionals. The transaction structure typically involves B2B agreements where firms pay for visibility and promotional content on the site, allowing them to reach decision-makers and industry experts effectively. In addition to ad placements, Labiotech.eu offers subscription-based access to exclusive content and resources that cater to industry professionals seeking deeper insights and analyses. While specific pricing structures for advertisements and subscriptions are not disclosed, the company’s business model focuses on creating value for clients by enhancing their brand presence within the biotech community. By maintaining a robust and engaged audience, Labiotech.eu positions itself as a vital resource for companies looking to connect with the life sciences sector.Following its recent acquisition by Inova Software SA in January 2022, Labiotech UG is expected to leverage synergies for expansion in the biotechnology media landscape. The company plans to introduce new products tailored for biotech professionals and aims to expand its reach into new geographic markets, particularly targeting increased engagement in the United States and the United Kingdom by the end of 2023. The recent acquisition is anticipated to provide the necessary resources and support for these growth initiatives.

## Funding rounds

- Seed, Sep 18, 2017 — WestTech Ventures, Wille AG, Indiana Capital, JOT-Berlin, Iduskia
- Seed, Feb 2, 2016 — WestTech Ventures, Adveris

## Investors

- WestTech Ventures (https://capitalatlas.ai/funds/westtech-ventures) — Seed
- Adveris — Seed
- Wille AG — Seed
- Indiana Capital — Seed
- JOT-Berlin — Seed
- Iduskia — Seed